Best Thyroid function tests (including T3, T4, TSH) doctors: TOP 79 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood
Ilker Tolga Özgen
  • New
  • 26 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Education

    • Undergraduate: Faculty of Medicine, Istanbul University, 1993-1997
    • M.Sc: Faculty of Medicine, Istanbul University, 1997-1999
    • Specialization: Pediatrics, Ondokuz Mayıs University, 1999-2004
    • Subspecialty: Pediatric Endocrinology, Ondokuz Mayıs University, 2004-2007
    •  

    Experience

    • Ar.Gör. (Research Assistant): Ondokuz Mayıs University Faculty of Medicine, 1999-2004
    • Research Assistant (Minor Research Assistant): Ondokuz Mayıs University Faculty of Medicine (Pediatric Endocrinology), 2004-2007
    • Assist. Assoc. Dr.: Ondokuz Mayıs University Faculty of Medicine, 2007
    • Uzm. Dr.: Gulhane Military Medical Academy (Military Service), 2007-2008
    • Uzm. Dr.: Bakırköy Obstetrics and Gynecology Training and Research Hospital (Compulsory Service), 2008-2011
    • Assoc: Bezmialem Vakif University Faculty of Medicine, 2011-2013
    • Assoc. Dr.: Bezmialem Vakif University Faculty of Medicine, 2013-2018
    • Prof. Dr.: Bezmialem Vakif University Faculty of Medicine, 2018-2023
    • Prof. Dr.: Biruni University, 2023-
    •  

    Scientific Memberships

    • National Pediatric Association
    • Pediatric Endocrinology and Diabetes Association
    •  

    Awards

    • Growth curves of Turkish girls with Turner syndrome: FAVOR Turner syndrome study group: 59th national pediatric congress 4-8 November 2015 ANTALYA PRIZE FIRST PRIZE FOR AN ORAL PRESENTATION
    • Anthropometric findings and karyotype in Turner syndrome: National Turner syndrome database. 19TH UPEK 22-25 OCTOBER 2015. POSTER SECOND PRIZE
    • Investigation of the Role of Irisin in the Pathophysiology of Puberty Precox in Female Rats. Esra Kutlu, İlker Tolga Özgen, Huri Bulut 24th UPEK Short Oral Presentation First Prize.
    •  

    Medical Interests

    • -Growth Retardation
    • -Puberty Problems (Early or Late Puberty)
    • -Menstrual Irregularities in Adolescent Girls
    • -Increased Hair Growth in Adolescent Girls
    • -Diabetes
    • -Obesity
    • -Thyroid Problems
    • -Pituitary Disorders
    • -Genital Abnormalities
    • -Micropenis and Gynaecomastia in Boys
    • -Adrenal Gland Disorders
  • Read more
Doctor's visit
Price on request
Ayse Kubat Uzum
  • New
  • 27 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Education

    • Undergraduate: Çukurova University, Faculty of Medicine 1992-1998
    • Specialty Education: Istanbul Training and Research Hospital 1998-2003
    • Subspecialization: IU Istanbul Faculty of Medicine 2004-2007
    •  

    Experience

    • Istanbul Training and Research Hospital 1998-2003
    • IU Istanbul Faculty of Medicine 2004-2007
    • Istanbul Training and Research Hospital 2007-2009
    • Şanlıurfa Training and Research Hospital 2009-2011
    • Bağcılar Training and Research Hospital August 2011- November 2011
    • Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases December 2011- 2014
    • Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2014-2020
    • Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2020-2024

     

    Scientific Memberships
     

    • Turkish Society of Endocrinology and Metabolic Diseases (Vice President)
    • European Society of Endocrinology;
    • Endosociety

     

    Awards

     

    1. 1. Bestclinical scientific publication support award (53rd National Diabetes Congress, 2017)
    2. 2. 54th National Diabetes Congress (2018) with the study titled "The effects of adding pre-probiotics to the diets of patients with gastric bypass (GBP) on metabolic parameters, icretin levels and hunger, satiety and appetite scores of patients".

    Medical Intrests

    • Diabetes
    • Thyroid diseases (hypothyroidism, hyperthyroidism, thyroid nodules)
    • Pituitary diseases
    • Adrenal gland diseases
    • Osteoporosis
  • Read more
Doctor's visit
Price on request
Yusuf Acikgoz
  • 4.5 Good 3 reviews
  • 9 years of experience
  • Turkey, Ankara, Lokman Hekim University Ankara Hospital
  • Associate Professor Dr. Yusuf AÇIKGÖZ
    Specialization: Medical Oncology

    Education:

    • 2004-2011: İnönü University Faculty of Medicine
    • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
    • 2017-2022: Health Sciences University, Medical Oncology

    Professional Experience:

    • 2016-2017: Bingöl City Hospital, Internal Medicine
    • 2021-2022: Health Sciences University, Medical Oncology
    • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
    • 2023-2024: Ohio State University, Medical Oncology
    • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

    Clinical Trials, Courses, Certifications:

    Clinical Trials:

    • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
    • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

    Courses:

    • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
    • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
    • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
    • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
    • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

    Certifications:

    • Ongoing: ECFMG Certification
    • 2024: CITI Responsible Conduct of Research (The Ohio State University)
    • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
    • 2024: CITI Human Subjects Protection (The Ohio State University)
    • 2024: CITI Good Clinical Practice (The Ohio State University)
    • 2023: Occupational English Test (OET)
    • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
    • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
    • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

    Memberships:

    • American Society of Clinical Oncology (ASCO) - 2022
    • Turkish Society of Medical Oncology - 2020
  • Read more
Doctor's visit
Price on request
Cigdem Arslan
  • 5 Excellent 2 reviews
  • 18 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience 

    • 2016 - 2017

    İSTİNYE UNIVERSITY FACULTY OF MEDICINE

    • 2016 - 2017

    Liv Hospital

    • 2016 - 2017

    Liv Hospital Ulus

    • 2015 - 2016

    Acıbadem Bodrum Hospital

    • 2014 - 2015

    Tatvan State Hospital

    • 2013 - 2015

    Tatvan State Hospital

    • 2012 - 2013

    CLEVELAND CLINIC

    • 2007 - 2014

    Dokuz Eylul University Faculty of Medicine

    Education 

    • 2013

    DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE, FACULTY OF MEDICINE/DEPARTMENT OF SURGICAL MEDICAL SCIENCES/DEPARTMENT OF GENERAL SURGERY

    • 2013

    Dokuz Eylül University, General Surgery

    • 2007

    AKDENİZ UNIVERSITY, FACULTY OF MEDICINE

    • 2007

    International Peer-Reviewed Journal Articles:

    Title: The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.

    • Authors: AĞALAR CİHAN, SÖKMEN SELMAN, ARSLAN ÖZŞAHİN NACİYE ÇİĞDEM, ALTAY CANAN, BAŞARA AKIN IŞIL, CANDA ARAS EMRE, OBUZ FUNDA
    • Journal: Techniques in Coloproctology
    • Year: 2020
    • Volume: 24(4)
    • Pages: 301-308
    • DOI: 10.1007/s10151-020-02159-z
    • Publication Number: 6776368

    Title: Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.

    • Authors: Terzi Cem, Bingül Mustafa, ARSLAN NACİYE ÇİĞDEM, ÖZTÜRK ERSİN, CANDA ARAS EMRE, IŞIK ÖZGEN, YILMAZLAR AHMET TUNCAY, OBUZ FUNDA, Görken Birkay, KURT MERAL, ÜNLÜ ŞADİYE MEHTAT, UĞRAŞ NESRİN, Kanat Özkan, ÖZTOP İLHAN
    • Journal: Colorectal Disease
    • Year: 2020
    • Volume: 22(3)
    • Pages: 279-288
    • DOI: 10.1111/codi.14867
    • Publication Number: 6012919

    Title: The effect of fibrin glue in preventing staple-line leak after sleeve gastrectomy: an experimental study in rats.

    • Authors: ÖZDENKAYA YAŞAR, OLMUŞÇELİK OKTAY, BASIM PELİN, SAKA BURCU, ARSLAN NACİYE ÇİĞDEM
    • Journal: Acta Cirurgica Brasileira
    • Year: 2019
    • Volume: 34(8)
    • Publication Number: 5242669

    Title: Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.

    • Authors: CANDA ARAS EMRE, ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, YAVUZŞEN TUĞBA, Ozkardesler Sevda, Unlu Mehtat, OBUZ FUNDA, FÜZÜN MEHMET
    • Journal: World Journal of Surgical Oncology
    • Year: 2018
    • Volume: 16(1)
    • Pages: 70-74
    • DOI: 10.1186/s12957-018-1369-7
    • Publication Number: 4863133

    Title: Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid–low rectal cancer.

    • Authors: Atasoy Gulsen, ARSLAN NACİYE ÇİĞDEM, Elibol Funda, SAĞOL ÖZGÜL, OBUZ FUNDA, SÖKMEN SELMAN
    • Journal: Surgery Today
    • Year: 2018
    • Volume: 48(12)
    • Pages: 1040-1051
    • DOI: 10.1007/s00595-018-1690-3
    • Publication Number: 4863005

    Title: Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?

    • Authors: Terzi Cem, Sokmen Selman, ARSLAN NACİYE ÇİĞDEM, Ozkardesler Sevda, DURAL CEMIL, OBUZ FUNDA, CANDA ARAS EMRE, GÖKTÜRK ÜMIT KELEŞTEN
    • Journal: International Journal of Surgery
    • Year: 2018
    • Volume: 51
    • Pages: 156-160
    • DOI: 10.1016/j.ijsu.2018.01.010
    • Publication Number: 4855751

    Contributions to Conferences:

    Title: Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A single-center experience.

    • Authors: CANDA ARAS EMRE, Sokmen Selman, Terzi Cem, ARSLAN NACİYE ÇİĞDEM, OBUZ FUNDA
    • Conference: European Society of Surgical Oncology (ESSO) Congress
    • Year: 2018
    • Location: Budapest, Hungary

    Title: Predictive factors for conversion to open surgery in laparoscopic colorectal surgery.

    • Authors: ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, CANDA ARAS EMRE, OBUZ FUNDA
    • Conference: European Association for Endoscopic Surgery (EAES) Congress
    • Year: 2017
    • Location: Frankfurt, Germany
  • Read more
Stereotaxic surgeries
$5,000 - $9,000
Radiation therapy for colorectal cancer
$4,000 - $6,000
Mohs microsurgery
$1,500 - $1,500
Nail Paksoy
  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Stereotaxic surgeries
$5,000 - $9,000
Radiation therapy for colorectal cancer
$4,000 - $6,000
Mohs microsurgery
$1,500 - $1,500
Ramazan Yunus Gul
  • New
  • 35 years of experience
  • Turkey, Istanbul, Medipol University Pendik Hospital
  • Education 

    2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine 

    1990 Erciyes University, Faculty of Medicine 

     

    Experience 

    2019 - 2019 Okan University Hospital 

    2018 - 2019 Ibn Sina Hospital 

    2003 - 2018 Pendik State Hospital 

    1997 - 2003 Haydarpasa Numune Hospital 

    1990 - 1994 Erzincan State Hospital 

    Istanbul Haydarpasa Numune Hospital 

    Kartal Health Group Presidency 

    Yıldırım Beyazıt Mother and Child Health Physician 

     

  • Read more
Doctor's visit
Price on request

Find out about the best doctors here

20 top ranked Thyroid function tests (including T3, T4, TSH) doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Thyroid function tests (including T3, T4, TSH) doctors on Bookimed.com:

How to choose the best Thyroid function tests (including T3, T4, TSH) doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Thyroid function tests (including T3, T4, TSH) doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Thyroid function tests (including T3, T4, TSH) varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Thyroid function tests (including T3, T4, TSH) if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Volkan Kinas
  • 4.5 Good 3 reviews
  • 10 years of experience
  • Turkey, Istanbul, Büyük Anadolu Hospitals (BAH)
  • Specializations

     

    Cancer Surgery

    Pancreatic Surgery

    Bile Duct Surgery

    Bariatric Metabolic Surgery

    Oncological Surgery

    Breast Surgery

    Gastric cancer

    Colon cancer

    Thyroid Cancer

    Obesity Surgery

    Diabetes Surgeries

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

  • Read more
Doctor's visit
Price on request
Muzaffer Al
  • 4.5 Good 3 reviews
  • 15 years of experience
  • Turkey, Istanbul, Büyük Anadolu Hospitals (BAH)
  • Education

     

    Ondokuz Mayıs University Faculty of Medicine (1991)

    KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)

    Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)

    Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)

    Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)

     

     

     

     

  • Read more
Doctor's visit
Price on request
Gonul Catli
  • 5 Excellent 6 reviews
  • 26 years of experience
  • Turkey, Istanbul, Liv Hospital Vadistanbul
  • Medical Interests 

    Obesity 

    Insulin resistance 

    Diabetes 

    Hypoglycemia (low sugar) 

    Growth retardation and short stature 

    Anorexia 

    growth hormone deficiency 

    Puberty problems (early puberty, delayed puberty, excessive hair growth, menstrual irregularity, polycystic ovary syndrome) 

    Turner syndrome 

    Thyroid diseases (Goiter, hypothyroidism, hyperthyroidism, Hashimoto’s disease, thyroid nodule) 

    Sexual development disorders (small penis, undescended testis, gender ambiguity, hypospadias) 

    Adrenal gland diseases (Congenital adrenal hyperplasia, Addison’s disease, Cushing’s syndrome) 

    Bone and calcium metabolism diseases (rickets, vitamin D deficiency, osteoporosis) 

    Education 

    Bachelor’s - Master’s: Ankara University Faculty of Medicine (1998-2004) 

    Ph.D. - Specialization in Medicine: Child Health and Diseases, Dr. Sami Ulus Gynecology and Childhood Health and Diseases Training and Research Hospital (2005-2010) 

    Ph.D. - Minor specialization: Pediatric Endocrinology, Dokuz Eylul University Faculty of Medicine (2010-2013) 

    Experience 

    Child Health and Diseases Specialist Diyarbakır Children’s Hospital 2010 

    Pediatric Endocrine Minor Assistant Dokuz Eylül University Medical Faculty Hospital 2010-2014 

    Pediatric Endocrinology Specialist İzmir Tepecik Training and Research Hospital 2014-2015 

    Assistant Professor Izmir Katip Celebi University Faculty of Medicine 2015-2016 

    Associate Professor Izmir Katip Celebi University Faculty of Medicine 2016-2021 

    Pediatric Endocrinology Associate Professor Ulus Liv Hospital 2021- Present 

    Pediatric Endocrinology Associate Professor Vadistanbul Liv Hospital 2021- Present

    Memberships 

    Aegean Child Endocrine and Diabetes Association, Member, 2010 

    Pediatric Endocrinology and Diabetes Association, Member, 2010 

    Growing Child Association, Member, 2014 

    European Society of Pediatric Endocrinology (ESPE), Member, 2016

  • Read more
Doctor's visit
Price on request
Philipp Riss
  • 4.6 Excellent 18 reviews
  • 20 years of experience
  • accreditations:
  • Austria, Vienna, Vienna General Hospital (AKH)
  • Dr. is a Team Leader in Surgical Endocrinology at the Medical University of Vienna and a Specialist in general and visceral surgery. He has a Doctorate in Medicine from 2005 and has held a variety of positions since then, including Assistant Professor, Doctor's Assistant, University Professor, Senior Physician, and Head of the Surgical Endocrinology Working Group. He is a member of several societies and has been awarded the Venia Docendi Award and the Sandoz Award for Thyroid Research.

  • Read more
Doctor's visit
Price on request
Mohd Nasir Bin Othman
  • New
  • 27 years of experience
  • Malaysia, Ampang Jaya, Klinik De Palma
  • Dr. Mohd Nasir Bin Othman is a specialist in a variety of cosmetic procedures, including rhinoplasty, breast lift, Botox injections, stem cell rejuvenation therapy, PRP Hair Loss Treatment, and laser skin resurfacing.
  • Read more
Doctor's visit
Price on request
Manish Rajput
  • New
  • 9 years of experience
  • India, Jaipur, Infinity Endovascular Clinic
  • Dr. Manish Rajput is an Interventional Radiologist with over five years of experience, specializing in Vascular and Onco (Cancer) Interventions. He has extensive training from Tata Memorial Hospital in Mumbai, with qualifications including DNB, FVIR, PDCC, and FRCR (Scholar). Dr. Rajput offers procedures such as Dialysis, Embolization of varicocele, Urethroplasty, and Uretheroplasty. He has led the largest team of Interventional Radiologists in the state.
  • Read more
Surgeon's portfolio
Doctor's visit
Price on request
Elnur Sahibov
  • 4.2 Good 32 reviews
  • 9 years of experience
  • Turkey, Istanbul, Emsey Hospital
  • Licensed Radiation Oncologist with 8 years of medical training, including undergraduate studies at Marmara University Faculty of Medicine (2004-2011) and Radiation Oncology specialization training at Marmara University Faculty of Medicine (2012-2016). Previous education from Sixteen Numbered Shirvan School (Azerbaijan) High School (1998-2004).

  • Read more
Lung segmentectomy
$12,000 - $20,000
Colectomy (large bowel resection)
$11,000 - $16,000
Doctor's visit
Price on request
Ilker Nihat Okten
  • 3.5 Good 3 reviews
  • 19 years of experience
  • Turkey, Istanbul, Istanbul Oncology Hospital
  • Dr. Ilker Nihat Okten is a medical oncologist who is board certified by the European Society of Medical Oncology (ESMO). He has been involved as a sub investigator in multiple phase III clinical trials for various cancers and has several publications in the field of oncology.
  • Read more
Radiotherapy
$2,000 - $4,500
Radiotherapy for prostate cancer
$2,000 - $4,500
Radiotherapy for lung cancer
$2,000 - $4,500
Raj Nagarkar
  • New
  • 29 years of experience
  • accreditation:
  • India, Nashik, HCG Manavata Cancer Centre
  • Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

  • Read more
Tongue cancer surgery
$5,900 - $8,000
Stomach cancer surgery
$2,500 - $8,500
Chemotherapy for lung cancer
$1,100 - $1,250
Mucahit Gur
  • 4.2 Good 32 reviews
  • 16 years of experience
  • Turkey, Istanbul, Emsey Hospital
  • Dr. Mucahit Gur is an Internal Medicine Specialist with experience in areas such as Diabetes Mellitus, Hypertension, Obesity, Hyperlipidemia, and Thyroid Diseases. He has completed his Medical Doctor degree from Cerrahpaşa Faculty of Medicine and his specialization in Internal Diseases from Düzce University. He has worked in the Tokat Niksar State Hospital, Düzce University, Tokat Zile State Hospital, and currently in Emsey Hospital.
  • Read more
Lung segmentectomy
$12,000 - $20,000
Colectomy (large bowel resection)
$11,000 - $16,000
Doctor's visit
Price on request
Ismail Biri
  • New
  • 22 years of experience
  • Turkey, Ankara, Private Koru Ankara Hospital
  • Education

     

    İnönü Üniversitesi Tıp Fakültesi (ingilizce) 1995- 2002

     

    Work Experience

    Başbakanlık S.H.Ç.E.K. Genel Müdürlüğü Kurum Hekimliği (2003)

     

    Erciyes Üniversitesi Tıp Fakültesi Genel Cerrahi Uzmanlığı 2011

     

    Yüzüncü Yıl Üniversitesi Temel ve İleri Düzey Endoskopik Girişimler Eğitimi 2011

     

    İstanbul Hastanesi /Van 2011

     

    Özel Malatya Hastanesi / Malatya2012

     

    Bilgi Tıp Merkezi Keçiören /Ankara 2013

     

    Özel Koru Sincan Hastanesi Sincan/Ankara 2013

     

    Baş Tibb Mərkəzi /Baku Clinic Azerbaycan/Bakü 2013

     

    Yüksek İhtisas Üniversitesi Özel Koru Ankara Hastanesi 2019

     

    Özel Ankara Koru Hastanesi /Ankara 2019

    Medical Interests

    laparoscopic obesity
    Laparoscopic abdominal and inguinal hernia repairs (with the latest techniques)

    Postpartum laparascopic diastasis recti (the formation of a protrusion in the upper middle abdomen due to the separation of the muscles in the abdominal tissue) and abdominal hernias above the navel and and gobekustunde both diastasis recti repair and abdominal hernia repair from the skin with laparascopic scola method for the first time in Turkey laparascopic stomach hernia and antireflu surgery).  

    Laparoscopic gallbladder surgeries, including cleaning the bile duct with trans-cystic choledochal irrigation in patients with bile sludge and stones less than 5mm in the bile duct, performed in the same session

    Laparoscopic gallbladder surgeries in pregnant women during the 2nd and 3rd trimesters, i.e., after 12 weeks of pregnancy

    Laparoscopic Appendectomy in Pregnancy

    Anal disorders, anal fissures, all types of internal and external hemorrhoid surgeries, anal fissure, and anal fistula surgeries

    Thyroid surgeries and cancers, parathyroid surgeries and cancers

    Breast diseases and breast cancer surgery

    Oncological surgery; liver and gallbladder and bile duct surgeries, stomach cancer surgery, colon cancer surgery, and liver resections for metastatic liver tumors

  • Read more
Doctor's visit
Price on request
Ajith Kumar
  • 5 Excellent 1 review
  • 17 years of experience
  • accreditations:
  • United Arab Emirates, Dubai, Medeor 24x7 Hospital, Dubai
  • Dr. Ajith Kumar is an Endocrinologist with 18 years of experience as a Consultant. He began his career as an Endocrinology Senior Resident at PGIMER, Chandigarh. After obtaining a DM in Endocrinology, he completed 15 years of clinical practice. He served as an Assistant Professor in the Department of Endocrinology at medical colleges associated with NTR University of Health Sciences for two years. Andhra Pradesh, India. He has served as a Consultant Endocrinologist for three years in multiple multispecialty hospitals in Kerala, India. He has been practicing as an Endocrinologist in Dubai for the past nine years.

     

    Expertise

    Type 2 Diabetes, Type 1 Diabetes, And Diabetes in Pregnancy (GDM)

    Thyroid Function Abnormalities

    Thyroid Nodules, Thyroid Cancer Management, and Follow-Up

    Pituitary Gland Disorders, Including Tumors

    Hormone Induced Hypertension

    Adrenal Gland Disorders

    Growth Disorders

    Disorders of Puberty

    PCOS and other Ovarian Disorders

    Testicular Disorders

    Obesity

    Hyperlipidemia, Hyperuricemia, and Other Metabolic Conditions

    Osteoporosis, Vitamin D Deficiency, and Other Metabolic Bone Disorders Including Parathyroid Abnormalities

    Membership

    American Association of Clinical Endocrinology (AACE)

    The Endocrine Society

    Endocrine Society of India and Indian Thyroid Society

    Indian Association of Physicians

  • Read more
Doctor's visit
Price on request
Muhammed Gomec
  • 5 Excellent 1 review
  • 16 years of experience
  • Turkey, Sivas, Medicana Sivas Hospital
Doctor's visit
Price on request
Choosing Right Doctor and Clinic: Insider Tips
When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team